| Benjamin Lloyd, PA-C | |
|
10710 Fort St, Omaha, NE 68134-1230 | |
| (402) 354-1910 | |
| Not Available |
| Full Name | Benjamin Lloyd |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 5 Years |
| Location | 10710 Fort St, Omaha, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013557941 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 2425 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Nebraska Methodist Hospital | Omaha, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physicians Clinic Inc | 4880506062 | 497 |
News Archive
"Decision aids" in the form of informational brochures help get patients talking about their anesthesia and pain relief options, according to a study presented at the ANESTHESIOLOGY 2015 annual meeting. Shared decision making is critical to a more patient-centered process, as well as helping patients take an active role in their medical decisions.
The American College of Medical Genetics and Genomics is weighing in on the genome editing/CRISPR debate with a new Points to Consider statement, "Genome Editing in Clinical Genetics."
Isagenix International, a global health and wellness company, ended its annual Celebration 2015 Breakthrough event in San Diego today by raising more than $565,000 for Make-A-Wish® through fundraising and generous Associate and corporate pledges.
Discovery Laboratories, Inc., reports preliminary results from its Phase 2 clinical trial of Surfaxin® in children with Acute Respiratory Failure (ARF), a critical condition often caused in children by severe respiratory infections. The objective of the study was to evaluate the safety and tolerability of intratracheal administration of Surfaxin and to assess whether Surfaxin treatment could decrease the duration of mechanical ventilation in children with ARF.
Three researchers who are recipients of a collaborative grant from the Samuel Waxman Cancer Research Foundation have developed a new type of drug designed to kill non-Hodgkin lymphoma tumor cells. The breakthrough could lead to potential non-toxic therapies for cancer patients. The Foundation-funded investigators include Ari Melnick, M.D., of Weill Cornell Medical College, Alexander MacKerell, Ph.D., of the University of Maryland and Gilbert Priv-, Ph.D., of the University of Toronto.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Benjamin Lloyd, PA-C 4519 Woolworth Ave, Omaha, NE 68106-2051 Ph: (919) 491-9632 | Benjamin Lloyd, PA-C 10710 Fort St, Omaha, NE 68134-1230 Ph: (402) 354-1910 |
News Archive
"Decision aids" in the form of informational brochures help get patients talking about their anesthesia and pain relief options, according to a study presented at the ANESTHESIOLOGY 2015 annual meeting. Shared decision making is critical to a more patient-centered process, as well as helping patients take an active role in their medical decisions.
The American College of Medical Genetics and Genomics is weighing in on the genome editing/CRISPR debate with a new Points to Consider statement, "Genome Editing in Clinical Genetics."
Isagenix International, a global health and wellness company, ended its annual Celebration 2015 Breakthrough event in San Diego today by raising more than $565,000 for Make-A-Wish® through fundraising and generous Associate and corporate pledges.
Discovery Laboratories, Inc., reports preliminary results from its Phase 2 clinical trial of Surfaxin® in children with Acute Respiratory Failure (ARF), a critical condition often caused in children by severe respiratory infections. The objective of the study was to evaluate the safety and tolerability of intratracheal administration of Surfaxin and to assess whether Surfaxin treatment could decrease the duration of mechanical ventilation in children with ARF.
Three researchers who are recipients of a collaborative grant from the Samuel Waxman Cancer Research Foundation have developed a new type of drug designed to kill non-Hodgkin lymphoma tumor cells. The breakthrough could lead to potential non-toxic therapies for cancer patients. The Foundation-funded investigators include Ari Melnick, M.D., of Weill Cornell Medical College, Alexander MacKerell, Ph.D., of the University of Maryland and Gilbert Priv-, Ph.D., of the University of Toronto.
› Verified 5 days ago
Neil C Jouvenat Ii, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4242 Farnam St Ste 650, Omaha, NE 68131 Phone: 402-559-8600 | |
Jennifer M Vaughn, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 601 N 30th St, Omaha, NE 68131 Phone: 402-449-4590 | |
Karen R Schrader, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 988102 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-4015 Fax: 402-559-8715 | |
Bridget A Burke, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 988102 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-8000 Fax: 402-559-8746 | |
Ms. Robbie L Lane, P.A.-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 8111 Dodge St, Suite 237, Omaha, NE 68114 Phone: 402-354-5210 | |
Mr. Ray Everett Skelton, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 987400 Nebraska Medical Center, Omaha, NE 68198 Phone: 402-559-7592 | |
Kimberly Mccolley, P.A.-C. Physician Assistant Medicare: May Accept Medicare Assignments Practice Location: Emile @ 42nd St, Omaha, NE 68198 Phone: 402-559-4015 Fax: 402-559-8715 |